Induced Pluripotent Stem Cells Market Analysis, Share, Trend, Industry Report Forecast till 2032 | Lonza Group Ltd.,Evotec SE

Global Induced Pluripotent Stem Cells Market Size, Status, and forecast for the 2025-2032. The research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Induced Pluripotent Stem Cells Market industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data. Additionally, the report includes upstream and downstream analyses of key players, as well as global certainties and assurances. The report evaluates dynamic aspects such as forecast market information, Porter's Five Forces Analysis, sales estimates, wide product portfolio, market scenarios, and possibility studies.

The global induced pluripotent stem cells market size was estimated at USD 1.72 billion in 2023 and is projected to grow at a CAGR of 10.22% from 2025 to 2032.

Updated Version of Sample Report Included:
https://www.marketdigits.com/request/sample/4183

Market Dynamics:

The induced pluripotent stem cell industry has seen significant innovation in recent years, with the introduction of advanced technologies that have improved the efficiency and accuracy of data analysis. For instance, in July 2024, Accelerated Bio and Pluristyx developed clinical-grade iPSCs from human trophoblast stem cells.

The industry is observing a significant level of merger & acquisition activities. In addition, companies are entering into collaborations and partnerships to develop new products and therapies. For instance, in September 2023, Lineage Cell Therapeutics partnered with Eterna Therapeutics, Inc. to generate a novel hypoimmune iPSC.

The regulatory impact significantly impacts the induced pluripotent stem cell industry. Regulatory authorities are focusing on establishing stringent guidelines for biosafety, contamination control, cell line authentication, and other factors. This compliance with regulatory standards represents significant challenges that may limit the market's growth.

The industry is experiencing a high level of regional expansion, indicating rapid growth and increasing market presence across different geographic regions. This expansion is driven by several factors, including the increased research and development focused on iPSCs for regenerative medicine, disease modeling, and drug discovery.

Major Players in Induced Pluripotent Stem Cells Markets are:

Lonza Group Ltd.,Evotec SE,FUJIFILM Holdings Corporation,Abcam PLC,Horizon Discovery Ltd.,Cell Signaling Technology, Inc.,Cell Applications, Inc.,Invivogen,ALSTEM, LLC,Censo Biotechnologies Ltd.,Creative Bioarray,Creative Biolabs,Axol Bioscience Ltd.,ID Pharma Co., Ltd.,BlueRock Therapeutics, LLC

Industry News:

In April 2024, Shinobi, a manufacturer of iPSC-derived cell therapy, collaborated with Panasonic and Kyoto University, Japan, to develop a platform for iPS-T cell therapies.

In January 2024, the Abu Dhabi Stem Cells Centre (ADSCC) and the Kyoto University, Japan, collaborated to develop a new therapy against diabetes that uses pancreatic beta cells derived from human induced pluripotent stem cells.

In October 2023, STEMCELLS Technologies, Inc. announced the opening of its new facility in Ontario, leveraging its North American market presence.

In October 2023, QHP Capital acquired Applied StemCell, which was expected to scale up the manufacturing of various types of cells, including iPSCs.

"Connect with our team of research specialists and unlock the optimal solution for driving your business growth"

Global Induced Pluripotent Stem Cells Market Segmentation:

Derived Cell Type Outlook:
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others

Application Outlook:
Drug Development
Tissue Engineering & Regenerative Medicine
o Neurology
o Orthopedics
o Oncology
o Cardiovascular and Myocardial Infraction
o Diabetes
o Others
Toxicology Research
Disease Modeling

End-use Outlook:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Others

Know more about this report:
https://www.marketdigits.com/induced-pluripotent-stem-cells-market-1708503695

The following areas and countries are covered in the worldwide Induced Pluripotent Stem Cells Market file:

North America (US, Canada, Mexico)
Europe (Germany, France, UK, Russia, Italy)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE), Egypt, Nigeria, and South Korea)

North America dominated the market and accounted for a 36.12% share in 2023, owing to the robust research infrastructure related to novel therapeutics. Furthermore, the region benefits from substantial public and private funding for biotechnology and healthcare research and the expanding adoption of stem cell therapies.

Detailed industry forecast-Brief Introduction to the research report:

Additional information on company participants
Customized reports and analyst assistance are available upon request.
Recent market developments and potential future growth opportunities
Personalized regional/country reports upon request
New data sources are being integrated.
Increased focus on data privacy and security
Increased collaboration and co-creation

Discover More: Visit Our Website for Additional Reports!

https://www.marketdigits.com/wireless-electric-vehicle-charging-market-1690872135

https://www.marketdigits.com/automotive-pumps-market-1690977967

https://www.marketdigits.com/automotive-control-cable-market-1690979448

https://www.marketdigits.com/submarine-combat-systems-market

https://www.marketdigits.com/electric-boat-market

About Us

Founded in 2015, MarketDigits Consulting & Advisory Pvt Ltd is a leading business research and consulting firm. Our mission is to empower clients by identifying emerging opportunities and driving revenue growth across industries. We specialize in providing comprehensive market insights, advanced technology solutions, and actionable strategies that support operational and strategic decision-making.

With a focus on the full value chain, our expert team delivers high-quality syndicate research reports, proprietary databases, and consulting services to help clients navigate today's competitive and dynamic business environment. At MarketDigits, we use advanced analysis to uncover profitable opportunities, enabling businesses to make smart decisions and achieve sustainable success.

Contact Us:

+1 510-730-3200 | +1 276-206-2055

sales@marketdigits.com

1248 CarMia Way Richmond

VA 23235, United States

This release was published on openPR.